Evidence map›Paper›PMID 41497297›Full record

ReviewIndian journal of endocrinology and metabolism

Bone Health Assessment and Management among Survivors of Non-metastatic Breast Cancer: A Narrative Review.

Rebecca John, Kripa E Cherian, Patricia Sebastian, Rajesh Balakrishnan, Selvamani Backianathan, Thomas V Paul

Abstract readReview
In one paragraph

Review in Indian journal of endocrinology and metabolism. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Rebecca JohnDepartment of Endocrinology, Christian Medical College and Hospital, Vellore, Tamil Nadu, India.
Kripa E CherianDepartment of Endocrinology, Christian Medical College and Hospital, Vellore, Tamil Nadu, India.
Patricia SebastianDepartment of Radiation Oncology, Christian Medical College and Hospital, Vellore, Tamil Nadu, India.
Rajesh BalakrishnanDepartment of Radiation Oncology, Christian Medical College and Hospital, Vellore, Tamil Nadu, India.
Selvamani BackianathanDepartment of Radiation Oncology, Christian Medical College and Hospital, Vellore, Tamil Nadu, India.
Thomas V PaulDepartment of Endocrinology, Christian Medical College and Hospital, Vellore, Tamil Nadu, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breast cancer, the most common hormone responsive cancer, is on a rise both globally and in India. With increased longevity of breast cancer survivors, addressing long-term complications such as osteoporosis is crucial. Several mechanisms contribute to the bone loss seen in breast cancer patients, including age, post-menopausal status, chemotherapy, and other adjuvant therapies received. Appropriate evaluation and counselling on the risks of therapy with aromatase inhibitors on bone health are much needed. Timely initiation of anti-resorptive medication can help improve bone mass, reduce the incidence of fractures, and improve quality of life.

Indexed as

Aromatase inhibitor-induced bone lossbone healthbreast cancerosteoporosis

Identifiers

PMID41497297
PMCPMC12768321

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.